Mitsubishi UFJ Capital

Mitsubishi UFJ Capital is a venture capital firm established in 1974 and headquartered in Tokyo, Japan. The firm specializes in investing in a diverse range of sectors, including life sciences, information and communication technology (ICT), high technology, artificial intelligence, electronics, biotechnology, fintech, and healthcare. With a focus on fostering innovation, Mitsubishi UFJ Capital aims to support the growth of emerging companies and technologies that have the potential to make significant impacts in their respective fields.

Nobuyoshi Fukumoto

Managing Director

Muneki Handa

President

Takashi Hasegawa

Managing Director

Masafumi Houshiyama

Deputy President

Junichi Masuda

Managing Director and Founder

Yasufumi Matsuda

Director and Executive Officer

Shinsuke Sakamoto

Deputy President

Fumio Sugasawa

Director and Executive Officer

Junichi Taguchi

Investment Director

Past deals in Growth Stage

Manabie

Series B in 2025
Manabie is an education technology start-up focused on transforming the learning experience by integrating online and offline education. The company offers an innovative e-learning application that combines high-quality learning materials with personal coaching to foster self-study habits and practical thinking skills among students. This blended approach aims to create efficient learning environments that reduce reliance on traditional physical classrooms. By providing essential resources for both online and offline learning, Manabie seeks to enhance educational outcomes for students worldwide.

Linqmed

Series B in 2025
Developer of radiopharmaceuticals intended to offer treatment of cancer. The company engages in the research and development of therapeutic and diagnostic drugs for cancer using 64Cu which is a radioisotope of copper, enabling doctors to provide cancer treatments to the patients.

FactBase

Series B in 2025
FactBase specializes in DX's promotion of small and medium-sized enterprises that can support japan's manufacturing.

Logiless

Series B in 2025
Logiless is a cloud-based software solution designed for e-commerce businesses, focusing on integrated management of orders and inventory. The platform automates various aspects of the e-commerce workflow, from order placement to shipping, thereby reducing the need for manual intervention. By streamlining operations, it enhances efficiency while keeping costs low. This comprehensive tool allows warehouse operators to improve productivity and enables businesses to manage their inventory and orders in a cohesive manner, facilitating faster shipping and overall operational effectiveness.

Kamereo

Series B in 2024
Kamereo is a B2B distributor specializing in the food and beverage industry, utilizing technology to enhance the supply chain process for restaurants. The company provides a comprehensive marketplace that connects restaurants with suppliers, streamlining the purchasing and sourcing experience. With an emphasis on competitive pricing and user-friendly order management, Kamereo's platform allows businesses to efficiently track and analyze their orders. By simplifying the supply chain, Kamereo enables F&B store owners to save both time and money while prioritizing customer satisfaction.

Simple Form

Series B in 2024
Simple Form provides real-time information on all domestic corporations necessary for financial institutions. We will accelerate the time-consuming and labor-intensive research work of corporations and take on the role of new financial underpinnings.

Rege Nephro

Series B in 2024
Rege Nephro Co., Ltd., established in 2019 and based in Kyoto, Japan, is a biotech company focused on the research, development, production, and marketing of therapeutics for renal diseases. The company leverages induced pluripotent stem cell (iPSC) technology, sourced from the Center for iPS Cell Research and Application at Kyoto University, to create innovative treatments for kidney, liver, and pancreas conditions. Rege Nephro develops drugs that utilize core seeds technology, which includes pluripotent stem cells capable of producing erythropoietin (EPO) and specific nephron progenitor cell markers. This approach aims to minimize the reliance on dialysis among patients with renal failure by offering effective therapeutic alternatives. Additionally, the company produces kidney organoids designed for nephrotoxicity screening, facilitating drug discovery in applied research.

TriOrb

Series B in 2024
Triorb is a technology company focused on advancing robot mobility through innovative software and hardware solutions. It specializes in developing robotic technologies aimed at enhancing efficiency and safety within manufacturing environments. Triorb's movement system integrates a ball-driven omnidirectional mechanism with coordinated movement capabilities, enabling robots to transport various objects that cannot be handled by a single unit. This cooperative transportation system allows multiple robots to work together, improving operational effectiveness for businesses in need of automated solutions.

Jubo

Series B in 2024
Jubo is Asia's largest tech company dedicated to the often-overlooked market of senior care. With a great passion for creating a better person-centered care environment and next-gen aging life, Jubo has been developing holistic solutions and software systems via a team of multidisciplinary experts in mobile technology, user experience research, data science, and spatial design. Since 2019, Jubo has served 700 healthcare institutions, 40,000 residents, and 3,000 care professionals, while simultaneously 600 millions of data points. Jubo has been internationally recognized with awards and honors in innovation, technology, design, and business, and continues to deepen its technology capability with many more registered patents worldwide. Headquartered in Taipei, Jubo is now expanding across Asia Pacific and the North America region.

Grand Green

Series C in 2024
GRA&GREEN is an agribio startup that creates the next era of food and agriculture. They produce crops using the same amount of space and resources. The company aims to maximize output through a variety of approaches, such as increasing crop yields and improving storage stability. The goal of GRA&GREEN is to increase crops' use of fertilizer while increasing their resistance to pests and environmental challenges.

Aeterlink

Series B in 2024
Aeterlink is a developer of advanced wireless power transfer technology aimed at eliminating the need for wires in various applications. The company specializes in creating wireless devices that can be applied across multiple fields, including factory automation, robotics, smart homes, and medicine. By enabling the wireless transmission of power over distances, Aeterlink's innovations enhance efficiency, sustainability, and safety in industries, allowing for greater flexibility in device placement and reducing the risks associated with traditional wiring. Their technology represents a significant step toward a digital world that operates without the constraints of physical connections.

enechain

Series B in 2024
Enechain is a company focused on providing solar energy solutions through an innovative energy marketplace platform. This platform facilitates the trading of energy products by offering a price discovery function that helps users visualize fair market prices. Additionally, Enechain includes a distribution function that finalizes transactions and ensures the delivery of products based on these fair prices. By enabling users to efficiently buy and sell various energy products, Enechain aims to enhance transparency and accessibility in the energy market.

ATOMica

Series B in 2024
ATOMica Co. Ltd. is a company based in Miyazaki Prefecture, Japan, founded in 2019. The firm specializes in the planning, management, and expansion of co-working spaces and shared kitchen-cafe facilities. ATOMica provides versatile office space services that cater to various needs, including workspaces, conference rooms, event venues, and educational gatherings. By focusing on maximizing individual potential within collaborative environments, the company enables easy access to innovative spaces tailored to diverse requirements. Additionally, ATOMica offers event planning and management services to enhance the experience and functionality of its facilities.

Parallel

Series C in 2024
Parallel is a virtual hangout platform that allows sharing content with friends. On the social networking site Parallel, users can enjoy a variety of content while chatting with their close friends. It enables the creation of a room where anyone who has been invited may enter and can immediately begin speaking.

Emulsion Flow Technologies

Series B in 2024
Emulsion Flow Technologies is an environmental management company focused on rare metal recycling and the separation and purification of substances. The company has developed a solvent extraction method that aims to enhance the efficiency of these processes. By offering advanced technology tailored for the rare metal recycling industry, Emulsion Flow Technologies enables businesses to improve productivity, enhance the working environment, and increase both separation and purification capacities. Additionally, their innovations contribute to reducing the environmental impact associated with these operations.

Biophilia

Series B in 2024
Biophilia Inc., founded in August 2017 and located in Shibuya-ku, Tokyo, specializes in creating and delivering high-quality dog food. The company focuses on producing fresh, natural, and handmade dog food that adheres to stringent nutritional standards and is supervised by veterinarians. Biophilia sources fresh domestic meat and vegetables to ensure the food retains its aroma, color, and nutritional value. In addition to its core business of pet food production, Biophilia also engages in consulting, internet services, and consignment development related to pet care. Through its commitment to quality, Biophilia aims to provide dogs with suitable and nutritious food options.

Asilla

Series C in 2024
Asilla, Inc. is a Tokyo-based company that specializes in artificial intelligence-driven image and video analysis. Founded in 2015, Asilla offers an array of services, including AI-based Optical Character Recognition (OCR) and a platform for image recognition known as Asilla Image Recognition (AIR). The company's technology enables users to transform images and videos into actionable information, which includes capturing text data and censoring inappropriate content. Additionally, Asilla provides vehicle recognition capabilities that identify the manufacturer and model of vehicles from images. The company's solutions are applicable across various sectors, enhancing safety and security through monitoring operations that detect human behavioral anomalies and facilitate crime prevention. With an additional office in Hanoi, Vietnam, Asilla aims to address diverse needs in security, mobility, and smart city initiatives.

Trinity Technology

Series B in 2024
Trinity Technology is technology company that provides services related to asset protection and inheritance planning.

Xbit

Venture Round in 2024
Xbit provides a shift management system that assists shop owners in optimizing their business processes. The company's platform includes a chatbot service that enables users to gather employee availability and create efficient shift schedules. By addressing customer needs and implementing effective solutions, Xbit helps clients reduce operational costs while maintaining service quality through proper personnel allocation.

Micoworks

Series B in 2023
Micoworks is a planning and development platform that focuses on enhancing marketing strategies through improved communication. It offers tools designed for optimal communication and personalization of the customer experience. The platform enables businesses to categorize customer information effectively and automates various processes, including customer interviews, conversations, and reservations. This functionality allows clients to streamline their operations and develop their marketing strategies more efficiently.

Gexval

Series C in 2023
GEXVal Inc. is a drug discovery company based in Fujisawa, Japan, founded in 2018. The company focuses on the research and development of innovative treatments for rare and incurable diseases, particularly in the fields of psychiatry, neurology, and pulmonary arterial hypertension. GEXVal aims to enhance the health and quality of life for patients and families affected by these challenging conditions by providing cost-effective treatment options. Through its commitment to addressing the needs of those with intractable diseases, GEXVal strives to make a meaningful impact in the realm of healthcare.

MyDearest

Series C in 2023
MyDearest Inc. is a Tokyo-based company specializing in the development and publication of virtual reality (VR) games and experiences. Founded in 2016, the company focuses on creating unique VR content, including its flagship product, FullDive Novel, which offers an immersive VR novel experience. MyDearest provides a range of animated visual novels that leverage VR technology, allowing players to engage with stories from a first-person perspective. Additionally, the company offers VR consulting services, further contributing to the expansion of virtual reality in interactive storytelling.

DAIZ

Series C in 2023
DAIZ Inc., founded in 2015 and based in Kumamoto, Japan, specializes in the production and supply of plant-based meat products, notably under the brand name 'Miracle Meat.' Utilizing a proprietary process known as the 'Ochiai Germination Method,' the company transforms germinated soybeans into functional food substances that serve as healthy, plant-based alternatives to traditional meat. In addition to its production activities, DAIZ is involved in research and development focused on raw materials and drug discovery derived from germinated soybeans, further emphasizing its commitment to innovation in the plant-based food sector.

Hydro Powtech Japan

Series B in 2023
Hydro Powtech Japan is a food technology company using hydrolysis to convert waste into sustainable, allergen-free food products.

Acall

Series B in 2023
Acall offers a Smart Office platform that aims to create safe, secure, and comfortable work environments for users, regardless of location. Utilizing artificial intelligence and the Internet of Things, the platform automates and enhances workplace experiences, allowing for seamless management of employees and conference spaces. By facilitating a balanced integration of office and remote work, Acall enables individuals and organizations to design their workspaces according to their specific needs, fostering productivity and flexibility in various work settings.

Caddi

Series C in 2023
Caddi, Inc. is a technology company based in Tokyo, Japan, that specializes in providing solutions for the manufacturing sector. It operates an online ordering platform that facilitates the management of custom-made processed products and connects orders with processing plants. By utilizing a proprietary costing algorithm, the platform automatically identifies the most suitable factory for production, thereby helping businesses to reduce procurement costs and optimize quality, cost, and delivery (QCD). Additionally, Caddi offers an AI-driven data platform that enhances procurement intelligence and supply chain management, enabling companies to improve operational efficiency and expand their capacity.

LiLz

Series B in 2023
LiLz is a technology startup focused on enhancing fieldwork operations through the integration of machine learning and Internet of Things (IoT) technologies. The company has developed the LiLz Gauge, a low-power IoT camera that captures and analyzes data from analog meters, which can operate similarly to smart meters. By uploading images to the cloud, the system employs character and image recognition to streamline the monitoring process. Additionally, LiLz is advancing a sound search service, known as LiLz Sound Search, designed to detect abnormalities in equipment, further improving operational efficiency for clients. This innovative approach allows organizations to reduce on-site work while increasing productivity and accuracy in their operations.

GITAI

Series B in 2023
GITAI Inc. is a leading space robotics company based in Tokyo, Japan, established in 2016. The firm specializes in manufacturing humanoid telepresence robots to assist with tasks related to space exploration, particularly within space stations and lunar development. GITAI's product lineup includes the G1 robot, designed for general-purpose automation, the S1 robot for specific task automation, and the H1 manipulation system for remote operation of robots in space. By providing a reliable alternative to human labor, GITAI aims to enhance safety, improve efficiency, and significantly reduce operational costs in space activities. Their technology is intended to facilitate the construction and maintenance of satellites, space stations, and future habitats on the Moon and Mars, ultimately enabling more sustainable and cost-effective space exploration.

Vark

Series C in 2023
Vark is a company that specializes in virtual reality technology, focusing on the production of virtual concert experiences. Established in 2017 and based in Tokyo, Japan, Vark has developed a platform that allows users to engage in live performances within a Metaverse environment. This innovative platform enables individuals to attend events at scheduled times, providing access to immersive entertainment content and opportunities to enjoy performances by various artists. Through its unique approach, Vark aims to enhance the way audiences experience live music events in a virtual setting.

Techtouch

Series B in 2023
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.

Aculys Pharma

Series B in 2022
Aculys Pharma is a pharmaceutical company that develops drugs and innovative medical treatments for neurological and psychiatric disorders.

QunaSys

Series B in 2022
QunaSys is a developer of software focused on algorithm and application development to advance the practical use of quantum technology. The company aims to harness quantum properties to create technologies that traditional methods cannot achieve. Its platform simulates phenomena related to the quantum mechanical behavior of electrons and atomic nuclei, facilitating the execution of quantum chemistry calculation algorithms on both quantum computers and simulators. By bridging the gap between theoretical quantum physics and practical applications, QunaSys seeks to bring quantum technologies to the forefront, enabling researchers to effectively explore and utilize these advanced capabilities.

Matsuri Technologies

Series C in 2022
Matsuri Technologies is a real estate technology company based in Tokyo, Japan, founded in 2016. The company specializes in developing tools for vacation rental management, aimed at enhancing the efficiency of private property rentals. Its flagship product, m2m Systems, serves as an Airbnb management platform that assists operators in managing their accounts, communicating with guests, and automating check-ins, among other tasks. By collaborating with real estate brokerages, Matsuri Technologies provides comprehensive solutions that support various rental needs, including short-term rentals and meeting room bookings, helping operators streamline their business operations.

Infostellar

Series B in 2021
Infostellar make space communications infrastructure, & are now developing our cloud-based satellite antenna sharing platform, StellarStation. By lowering costs and increasing transmission time, Infostellar empowers satellite operators to improve the quality of their service and expand potential business.

Spider Labs

Series B in 2021
Spider Labs, Ltd. is a cybersecurity company based in Tokyo, Japan, specializing in the detection and prevention of online advertising fraud. Founded in 2011, the company develops an automated, AI-driven software known as Spider AF, which safeguards digital advertisements from fraudulent clicks and conversions. This tool enables ad tech businesses, advertisers, and ad agencies to effectively identify and block fraudulent activities through centralized fraud management and advanced analytics. By providing complete transparency in digital advertising, Spider Labs enables clients to track ad placement, recognize fraudulent behaviors, and access clean, fraud-free data, thereby enhancing the integrity of online advertising campaigns.

Luxonus

Series B in 2021
Luxonus is a medical device manufacturing company specializing in photoacoustic technology aimed at early disease detection and diagnosis. The company has developed an advanced imaging device that utilizes optical ultrasonic technology, which combines light and ultrasonic waves to create ultra-high-resolution three-dimensional images of blood vessels and lymphatic vessels. This innovative approach allows for safe and easy imaging without exposure, providing healthcare professionals with a comprehensive understanding of disease onset, healing processes, and overall health conditions before and after illness.

Parallel

Series B in 2021
Parallel is a virtual hangout platform that allows sharing content with friends. On the social networking site Parallel, users can enjoy a variety of content while chatting with their close friends. It enables the creation of a room where anyone who has been invited may enter and can immediately begin speaking.

Rehab

Series C in 2021
Rehab is a technology firm that offers information communication technology, and digital transformation services for the medical care field.

Axelspace

Series C in 2021
Axelspace is a startup company developing businesses in the microsatellite field. Axelspace plans to construct a monitoring platform to cover the entire globe on a daily basis at extremely low cost.

JCG

Series B in 2021
JCG specializes in e-sports tournament planning and management, providing services that encompass community engagement, promotion, and recreational activities. The company organizes both online and offline competitions, utilizing a user-friendly web system supported by cloud technology and its own distribution studio. This approach enables JCG to assist clients in developing and enhancing e-sports infrastructure effectively.

Funds

Series C in 2021
Funds is a loan investment firm that specializes in facilitating financing for businesses through an online peer-to-peer lending marketplace. The company connects individual investors with businesses seeking operating capital, allowing these investors to manage their assets and invest in financial instruments that offer moderate risk and returns. Through silent partnership agreements, Funds enables companies to invest in financing options in small increments, making it accessible for a wider range of investors and businesses. This model not only supports businesses in obtaining necessary funds but also provides a platform for individuals to participate in the lending process.

DAIZ

Series B in 2021
DAIZ Inc., founded in 2015 and based in Kumamoto, Japan, specializes in the production and supply of plant-based meat products, notably under the brand name 'Miracle Meat.' Utilizing a proprietary process known as the 'Ochiai Germination Method,' the company transforms germinated soybeans into functional food substances that serve as healthy, plant-based alternatives to traditional meat. In addition to its production activities, DAIZ is involved in research and development focused on raw materials and drug discovery derived from germinated soybeans, further emphasizing its commitment to innovation in the plant-based food sector.

LegalForce

Series C in 2021
LegalForce, Inc., founded in 2017 and headquartered in Toyosu, Tokyo, Japan, specializes in developing and maintaining AI-powered software for legal services, particularly in contract management. The platform employs natural language processing and other advanced technologies to assist legal professionals by reviewing contracts based on their type, identifying potentially omitted or risky clauses, and minimizing oversights. This functionality aims to enhance the quality and efficiency of legal operations, providing valuable support in the contract review process.

unilabo

Series B in 2020
Unilabo, Inc. operates a business-to-business (B2B) ordering platform based in Tokyo, Japan, founded in 2012. The company specializes in a supplier search service that provides detailed information on suppliers, subcontractors, and outsourcing companies. This service highlights the characteristics, achievements, and offerings of these entities, which are often difficult to discover through traditional search methods. Unilabo's platform, known as Aimitsu, enables users to compare service information and pricing across various sectors, including IT and information systems, sales and marketing, back office operations, and overseas expansion. This comprehensive approach supports businesses in making informed decisions when selecting suppliers and partners.

Japan Data Science Consortium

Series B in 2020
Japan Data Science Consortium (JDSC) is an AI company that provides solutions for the medical, education and retail areas. As a professional consulting company, JDSC provides holistic support, from system construction to corporate process transformation to realize real profit impact by leveraging AI technology.

Periotherapia

Series B in 2020
Periotherapia is a drug discovery company focused on developing targeted medical treatments for intractable diseases, with a particular emphasis on triple negative breast cancer as its primary indication. The company aims to selectively inhibit specific disease-related pathways, notably the ASV involved in disease pathogenesis, while preserving the physiological functions of ASV in chronic conditions such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. By utilizing disease-specific antibodies, Periotherapia contributes to early diagnosis and precision medicine through companion diagnostics, thereby enhancing the ability of healthcare professionals to discover new therapeutic options for these challenging diseases.

Social Interior

Series B in 2020
Social Interior is a furniture design platform that specializes in subscription services for new furniture and home appliances. The company aims to promote a sustainable lifestyle by offering a diverse range of furniture for rent, including chairs, tables, sofas, and kitchen storage. Through its online platform, customers can conveniently book sustainable furniture for specific periods, aligning with the company's goal of fostering a recycling society that values long-lasting products. Social Interior's services cater to the growing demand for flexible and eco-friendly home furnishing options.

CellAxia

Series B in 2020
CellAxia Inc., founded in 2017 and based in Tokyo, Japan, is a biotechnology startup focused on developing cell therapy drugs. The company aims to transform advanced research into practical applications in the healthcare sector, specifically targeting intractable autoimmune diseases. CellAxia specializes in the discovery, development, and commercialization of biological therapies, enabling researchers to utilize challenging cell types, such as primary and cancer stem cell cultures. Through its innovative approach, CellAxia seeks to create new therapeutic cell-based treatments, addressing unmet medical needs in the field of cell therapy.

DiscGenics

Series C in 2020
Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Taranis

Series C in 2020
Taranis operates an agriculture intelligence platform that leverages advanced computer vision, data science, and deep learning algorithms to monitor agricultural fields effectively. The platform provides high-precision aerial surveillance imagery, enabling farmers to detect early signs of issues such as weeds, nutrient deficiencies, crop diseases, insect infestations, and water damage. By offering detailed insights, Taranis helps agribusinesses make informed decisions that can prevent crop yield loss and enhance productivity.

AppBrew

Series C in 2020
AppBrew Inc. is a Japanese company founded in 2016 and headquartered in Tokyo. It specializes in the development of LIPS, a mobile application designed as a beauty-focused social media platform. LIPS allows users to share and read authentic reviews on a wide range of products, including cosmetics, nail care, personal care, and hair care from various brands. The application serves as a valuable resource for consumers seeking to gather information and insights about beauty products and accessories, making informed purchasing decisions.

LegalForce

Series B in 2020
LegalForce, Inc., founded in 2017 and headquartered in Toyosu, Tokyo, Japan, specializes in developing and maintaining AI-powered software for legal services, particularly in contract management. The platform employs natural language processing and other advanced technologies to assist legal professionals by reviewing contracts based on their type, identifying potentially omitted or risky clauses, and minimizing oversights. This functionality aims to enhance the quality and efficiency of legal operations, providing valuable support in the contract review process.

ArchiTek

Series B in 2020
ArchiTek is a hardware manufacturing company that focuses on the development of circuit designs for embedded systems. The company specializes in creating artificial intelligence and image-processing digital circuits that enhance the efficiency of data storage, processing, and analysis. ArchiTek's circuits enable computers to sense and interpret their environments in dynamic conditions, offering clients affordable and high-performance AI chips tailored for embedded applications.

LINK-US

Series B in 2020
LINK-US focuses on the contract sales of various devices applying ultrasonic combined vibration and powerful ultrasonic technology. LINK-US designs and manufactures bonding equipment for a wide range of similar and dissimilar metal materials related to room temperature bonding technology using ultrasonic compound vibration and various equipment that employs these technologies.

Numab

Series B in 2019
Numab is a biotechnology company focused on developing antibody-based therapeutics for severe diseases, including chronic inflammation and cancer. The company employs a plug-and-play platform that minimizes the randomness typically associated with the drug discovery process, allowing for the predictable creation of multispecific biotherapeutics. This platform facilitates the development of mono- or multispecific antibody fragment-based therapeutics with customized pharmacokinetic properties, enabling the healthcare sector to address multiple therapeutic targets simultaneously. Through its innovative approach, Numab aims to enhance the effectiveness of immunotherapies in treating complex medical conditions.

Unifa

Series C in 2019
UniFa is the developer of LookMee, an AI and IoT-powered healthcare solution for tracking kindergarteners' physical and mental growth. The system consists of LookMee Nap Check, an IoT sensor that aims to secure a baby's naptime; LookMee thermometer, which measures and monitors the baby's body temperature; and LookMee Photo, a communication and photo-sharing service that collects data from children at kindergarten to give parents a better idea of their child's well-being

Funds

Series B in 2019
Funds is a loan investment firm that specializes in facilitating financing for businesses through an online peer-to-peer lending marketplace. The company connects individual investors with businesses seeking operating capital, allowing these investors to manage their assets and invest in financial instruments that offer moderate risk and returns. Through silent partnership agreements, Funds enables companies to invest in financing options in small increments, making it accessible for a wider range of investors and businesses. This model not only supports businesses in obtaining necessary funds but also provides a platform for individuals to participate in the lending process.

Crowdport, Inc.

Venture Round in 2019
Crowdport operates “Funds,” a P2P platform, connecting individual investors who wish to manage their assets with companies that wish to borrow operating funds.

Atmoph

Series B in 2019
Atmoph Inc., founded in 2014 and based in Kyoto, Japan, specializes in the development of Atmoph Window, a smart digital window that provides immersive experiences by displaying 4K videos and sounds of scenic locations from around the globe. This innovative product aims to transform the way individuals engage with nature and information at home, enhancing their quality of life. By offering a diverse selection of visual and auditory landscapes, Atmoph Window enables users to create a tranquil and enjoyable environment, effectively bringing the beauty of the outdoors into their living spaces.

Araya

Series B in 2019
Araya Inc. is a Tokyo-based company that specializes in developing artificial intelligence software solutions. Founded in 2013, the company focuses on deep learning algorithms that facilitate real-time image recognition and processing services, enabling the identification of various individuals and objects in images and videos. Araya's technology also includes deep reinforcement learning, allowing for the autonomous movement of drones and robots. Additionally, the company has developed a unique deep learning compression technology that enhances the efficiency of its algorithms, making them smaller and faster while maintaining accuracy. By aiming to advance the capabilities of artificial intelligence towards potential artificial consciousness, Araya seeks to address the diverse needs of its clients through innovative AI services.

Kyash

Series B in 2019
Kyash Inc. is a Japanese fintech startup founded in 2015 and headquartered in Tokyo. The company develops a mobile wallet application and payment platform that enables users to make payments at Visa merchants and conduct peer-to-peer transfers. Kyash offers a proprietary technology platform that allows businesses to issue their own Visa cards instantly through APIs, enhancing their payment processing capabilities. The services provided by Kyash include sending and requesting money quickly and securely using virtual and prepaid cards, making it a convenient option for users seeking efficient money transfer solutions.

Kyulux

Series B in 2019
Kyulux, Inc. is a company based in Fukuoka, Japan, specializing in the research and development of organic electroluminescence materials for organic light-emitting diode (OLED) displays and lighting. Founded in 2015, Kyulux focuses on developing thermally activated delayed fluorescence (TADF) technology and offers a product known as Hyperfluorescence, which combines TADF with fluorescence emitters to enhance emission efficiency. The company holds an extensive intellectual property portfolio related to TADF, largely developed through collaborations with Kyushu University and industrial partners over the past seven years. By providing these innovative OLED materials, Kyulux enables manufacturers in the display and lighting sectors to create cost-effective, durable, and efficient products without relying on rare metals.

DIV

Venture Round in 2019
DIV Inc., founded in 2012 and based in Tokyo, Japan, specializes in offering programming courses and training programs. The company operates TECH::CAMP, a programming school that provides short-term intensive training designed to transform students into skilled engineers. DIV's programming schools are available in both online and classroom formats, catering to individuals looking to transition from inexperienced workers to professional engineers. This approach not only equips students with essential programming skills but also enhances their employability in the technology sector, particularly as web designers.

Holoeyes

Series B in 2019
HoloEyes Inc. is a Tokyo-based company founded in 2016 that specializes in developing virtual reality applications for the medical field. The company's platform allows healthcare professionals to transform CT scan data into three-dimensional images, facilitating better visualization and understanding of medical conditions. By creating a medical VR database from accumulated 3D human body models, HoloEyes aims to enhance surgical planning and diagnosis. The technology enables surgeons to simulate operations in a virtual environment, improving their ability to prepare for complex procedures. HoloEyes is focused on expanding its business and increasing its workforce to further develop its innovative VR healthcare solutions.

Trustdock

Series B in 2019
Trustdock Inc., founded in 2017 and based in Tokyo, Japan, specializes in identity verification solutions. The company offers an identity confirmation platform that provides an API service for Know Your Customer (KYC) processes, allowing businesses to outsource identity verification efficiently. Trustdock's platform complies with various Japanese laws, including those related to criminal profit transfer prevention and fraud prevention. It supports a wide range of applications, making it suitable for diverse sectors such as FinTech and shared economy services. By facilitating individual identity confirmation, personal number acquisition, and risk assessments, Trustdock enables individuals and businesses to authenticate digital identities in a convenient manner, fostering trusted business relationships and transactions.

ProteanTecs

Series B in 2019
ProteanTecs Ltd. is a software company that specializes in a cloud-based platform designed to enhance the performance and reliability of electronic systems. Founded in 2017 and headquartered in Haifa, Israel, with additional offices in Tel Aviv, Santa Clara, and Bridgewater, the company utilizes data generated by chip-embedded agents and machine learning to predict faults before they lead to failures. Its solutions deliver valuable insights across the entire value chain, benefiting chip vendors, system vendors, and digital service providers. ProteanTecs offers various capabilities, including predictive maintenance, yield improvement, and performance tuning, aimed at reducing defect parts per million (DPPM) and enhancing overall electronic performance and quality.

Chordia Therapeutics

Series B in 2019
Chordia Therapeutics Inc. is a clinical-stage biotechnology company based in Fujisawa, Japan, founded in 2017. The company focuses on the research and development of innovative oncology drugs aimed at addressing significant unmet medical needs in cancer treatment. Chordia Therapeutics is dedicated to delivering first-in-class therapeutic options to patients, emphasizing the importance of advancing cancer care through its specialized bioventure efforts.

Veritas In Silico

Venture Round in 2019
Veritas In Silico Inc., founded in 2016 and based in Tokyo, Japan, specializes in drug discovery focused on medium and small molecules, particularly those targeting messenger RNA (mRNA). Utilizing its proprietary ibVIS platform, the company integrates informatics with experimental biology to develop mRNA-targeted drugs, including small molecules and antisense oligonucleotides. Veritas In Silico aims to address unmet medical needs by providing effective treatments for diseases that currently have limited therapeutic options.

naturacart

Venture Round in 2019
naturacart is a natural and organic CtoC / BtoC marketplace that sells products selected by buyers around the world and products from overseas brand manufacturers that have not yet arrived in Japan. The lineup ranges from beauty and health care products to wine, food and sportswear. The company sells products mainly for women, and is characterized by the ability to purchase foreign-made products that are not yet available in Japan. We have high-quality products carefully selected by manufacturers, distributors, shops and buyers in about 50 countries around the world.

Modulim

Series B in 2019
Modulim is a leader in light-based imaging technology focused on tissue and vascular assessment through spatial frequency domain imaging (SFDI). The company has developed the Clarifi Imaging System, which aids clinicians in identifying patients at risk for complications such as diabetic foot ulcers and amputations due to compromised circulation. By enabling timely interventions, this technology plays a crucial role in preserving patients' limbs and lives. Additionally, Modulim's devices are applicable in research, aesthetics, and medicine, providing professionals with transformative tools for the prevention, diagnosis, and treatment of various medical skin conditions.

Cart

Series B in 2019
Cart Ltd. is a Tokyo-based company founded in 2016 that operates Naturacart, an online platform specializing in the sale of natural and organic products. The platform offers a diverse range of items, including wine, diapers, beauty care products, oils, spices, breads, dairy products, supplements, stationery, and toiletries. Cart enables consumers in Japan to access wellness products sourced from around the globe, catering to the growing demand for health-conscious and environmentally friendly options.

Ball Wave

Series B in 2018
Ballwave uses the ball SAW sensor based on a new principle as the core of the differentiating factor, and becomes the human eye and the nervous system, and invites it to the horizon of technology.

Uncover Truth

Venture Round in 2018
Uncover Truth is an analytics company that specializes in data visualization and content analytics services for web and mobile platforms. The company develops tools that analyze customer behavior by examining websites through both quantitative and qualitative data. These tools utilize methods such as form analysis, session playback, and click heatmaps to deliver insights into user behaviors and identify potential user experience issues. By providing this information, Uncover Truth enables website operators to better understand their customers and enhance their websites accordingly.

4D Sensor

Venture Round in 2018
4D Sensor specializes in the development, manufacturing, and sale of advanced measurement equipment that captures high-speed, high-precision data related to shape and deformation. Originating from university research, the company focuses on applying innovative technologies to real-world challenges, thereby contributing to societal advancements. Its multi-dimensional scanning technology is designed to accurately measure moving objects and can be utilized in various applications, including production lines with projectors and robots. Additionally, the scanner is capable of dynamically capturing distortions in large structures, such as buildings and bridges, as well as detecting ultra-fine movements. This enables industries to implement precise measurement methods for shape, deformation, and vibration analysis.

Hmcomm

Series B in 2018
Hmcomm specializes in AI-driven voice recognition and abnormal sound detection services tailored for business applications. The company provides a range of solutions, including cloud-based voice recognition, text recognition during voice calls, bone conduction technology, automatic answering machines, and tools for creating meeting minutes. By leveraging these technologies, Hmcomm aims to enhance operational efficiency for businesses, facilitating smoother communication and streamlined processes through advanced artificial intelligence.

sitateru

Series B in 2018
Sitateru is a cloud based garment production platform helping clothing companies improve workflow to control inventory and production needs.

CureApp

Series B in 2018
CureApp, Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing mobile applications aimed at treating various health conditions, particularly nicotine addiction. The company's flagship product, a nicotine addiction treatment app, was launched in February 2015 in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp is recognized as a prominent player in the digital health sector, focusing on applications that exhibit therapeutic effects against diseases. The company is actively conducting clinical trials to validate the efficacy of its applications. Additionally, CureApp's medical treatment platform allows users to keep daily activity logs, which are analyzed to identify triggers exacerbating their conditions. This technology enables patients to receive personalized guidance in managing lifestyle diseases, addressing health issues that are typically not managed by conventional medications or devices.

Megakaryon

Series C in 2017
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.

Stem Cell & Device Laboratory

Series B in 2017
Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.

toBe Marketing

Series B in 2017
ToBe Marketing is an information technology company based in Tokyo, Japan, founded in 2015. It specializes in integrating marketing automation with customer relationship management (CRM) to enhance corporate engagement with customers. The company provides consulting services in IT and marketing, focusing on the implementation and utilization of various marketing tools. These tools support a range of operations, including social media collaboration, email distribution, and salesforce integration. By leveraging digital technology, ToBe Marketing aims to improve the effectiveness of clients' marketing activities and drive sales growth.

DiscGenics

Series B in 2017
Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Capy

Series B in 2017
Capy is a software company that specializes in providing SaaS-based security solutions to protect websites from bot and human threats through innovative authentication methods and CAPTCHA technology. Aiming to address the common challenges faced by website visitors—where existing security solutions tend to be either overly complex or insufficiently secure—Capy has introduced a user-friendly CAPTCHA system. This solution is designed to be intuitive, requiring no special skills or tools for implementation. Capy is committed to advancing online security by continually developing new technologies, with the goal of establishing “Easy & Secure” as the standard in the industry. The company’s software also includes features to defend against password brute-force attacks, spam, and fraud, enabling businesses to safeguard their online presence effectively and effortlessly.

Coiney

Venture Round in 2017
Coiney develops "Coiney" credit card payment service for businesses using smartphones and tablets. By inserting a Coiney dedicated leader into the earphone jack of the mobile terminal and using a dedicated application, you can easily make credit card payment anytime, anywhere, indoors and outdoors with internet connection. Coiney Engine uses artificial intelligence to offer an evaluation of business enterprises based on the accumulation of payments history and various statistical data from the Coiney Terminal and Coiney Payge services. It is used to see the credibility of a company when they apply for business loans from banks partnering with the payments startup.

Cellspect

Series B in 2017
Cellspect is a biotechnology company focused on developing biomarker-sensing technology and in-vitro diagnostic agents aimed at improving the prognosis of endometriosis progression. The company creates analytical instruments and medical devices designed for point-of-care testing, facilitating timely diagnosis and treatment. By leveraging cloud technology, Cellspect enables the seamless sharing of diagnostic results, allowing patients to receive prompt and appropriate consultations regarding endometriosis and cancer treatment. This innovative approach aims to enhance the transition from clinical settings to health tech markets, ultimately contributing to better patient outcomes.

Astroscale

Series C in 2017
Astroscale is a pioneering company dedicated to addressing the increasing problem of orbital debris through innovative solutions for end-of-life satellite management and active debris removal. By developing scalable services across various aspects of on-orbit servicing, including life extension and in-space situational awareness, Astroscale aims to create sustainable space systems. The company collaborates with national space agencies, international institutions, non-profit organizations, insurance companies, and satellite operators to establish norms, regulations, and incentives that promote responsible space use. Through these efforts, Astroscale is not only providing technical solutions but also helping to define the business case for debris removal services.

Floadia

Series B in 2017
Floadia Corporation, established in 2011 and headquartered in Tokyo, Japan, specializes in the development, licensing, and sale of semiconductor intellectual property, particularly focusing on embedded non-volatile memory solutions. The company leverages its engineering team's extensive experience in embedded FLASH technology, which includes contributions from pioneers in the field. Floadia's technology is designed for use in various applications, including Internet of Things devices, automobiles, smartphones, and smart cards. Their embedded memory solutions offer low-power consumption and cost efficiency, while also providing durability suitable for automotive-grade environments. In addition to its product offerings, Floadia provides technology consulting services to support its clients in optimizing their semiconductor needs.

SMARTCAMP

Series B in 2017
Smart Camp is a technology company that offers SaaS comparison services, inside sales agency support, and B2B digital marketing solutions.

TMS

Series C in 2017
TMS is a Tokyo-based clinical-stage biotech company that unlocks fungus-derived SMTP small molecule compound group. SMTPs have novel dual mode of action, both thrombolytic and anti-inflammatory. The lead compound TMS-007 is in Phase IIa clinical trial indicated for acute ischemic stroke and partnered with Biogen.

Halio

Series C in 2017
Halio specializes in advanced smart-tinting glass that adapts to changing light conditions, enhancing architectural design and efficiency. Its innovative technology allows the glass to transition from clear to tinted or dark in seconds, providing shade, glare relief, and privacy as needed. Unlike traditional electrochromic glass, Halio's product offers uniform tinting without undesirable hues, achieving a natural glass appearance in various neutral shades. The company also provides sophisticated software and hardware controls that integrate seamlessly with building management systems. Halio’s manufacturing process ensures high yields akin to the flat panel display industry, allowing for reliable and timely deliveries worldwide. This transformative glass not only improves the comfort and aesthetics of buildings but also fosters a deeper connection between indoor environments and the outside world.

Laxus Technologies

Series B in 2017
Laxus Technologies operates an online fashion-sharing platform that specializes in the rental of designer handbags. The platform enables users to borrow high-end handbags for an unlimited duration, with the option for free replacements. This service allows women to access luxury fashion items in a cost-effective manner, catering to individual preferences and budgets. Through its application, Laxus Technologies facilitates seamless transactions, allowing consumers to acquire goods directly from sellers via a web browser or mobile app.

Promethera Biosciences

Series C in 2016
Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.